Form 4 for BOLT Bolt Biotherapeutics, Inc.

Accepted 2022-02-01 00:00:00 ET · period of report 2021-12-22 · accession 0000899243-22-003917 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-02-01	2021-06-04+	BOLT	Perez Edith A.	Chief Medical Off	P - Purchase	$12.93	+1,328	1,328	New	+$17.2K
D	2022-02-01	2021-12-22	BOLT	Perez Edith A.	Chief Medical Off	M - OptEx	$2.80	+35.7K	37.0K	+2,689%	+$100.0K
D	2022-02-01	2021-12-22	BOLT	Perez Edith A.	Chief Medical Off	M - OptEx	$0.00	-35.7K	189.3K	-16%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-06-04	P	A	917	$16.65	917	D	—	—	(F1) These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
2	Common	Common Stock	2021-12-06	P	A	411	$4.64	1,328	D	—	—	(F1) These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
3	Common	Common Stock	2021-12-22	M	A	35,714	$2.80	37,042	D	—	—
4	Derivative	Stock Option (Right to Buy)	2021-12-22	M	D	35,714	$0.00	189,286	D	$2.80 · — to 2030-07-28	35,714 Common Stock	(F2) 1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.